Beurteilung einer biologischen Zelle unter Verwendung der gesamten Genomsequenz und Planung einer onkologischen Therapie damit

Details

Veröffentlichungs-Nr.

EP2602733

Aktenzeichen

EP11193637

Anmeldetag

15. Dezember 2011

Veröffentlichung

14. August 2013

Rechtsraum

EP

IPC

G06F19/18

Abstract

A cancer test includes: processing a suspect tissue sample (10) acquired from a subject (6) to generate a suspect whole genome sequence (WGS) (20) ; processing a normal tissue sample (12) acquired from the subject to generate a normal WGS (22) ; computing a WGS comparison metric comparing the suspect WGS with the normal WGS; and identifying whether the suspect tissue sample comprises cancer tissue based on the computed WGS comparison metric. A tumor delineation method comprises: acquiring a plurality of probative tissue samples (104) from a subject (6) in or near a tumor (100) ; recording the sampling locations of the probative tissue samples; classifying each probative tissue sample respective to cancer based on genetic testing of the probative tissue sample; and delineating a boundary (110) of the tumor based on the classifications of the probative tissue samples and the recorded sampling locations.

Anmelder

Firmen

Koninklijke Philips N.V.
Koninklijke Philips Electronics N.V.

Land

🇳🇱 Niederlande

Fachgebiete